ACB - Aurora Cannabis Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
7.03
-0.30 (-4.09%)
As of 10:18AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close7.33
Open6.73
Bid6.87 x 4000
Ask6.88 x 4000
Day's Range6.62 - 7.08
52 Week Range4.05 - 12.52
Volume14,283,795
Avg. Volume16,073,593
Market Cap7.018B
Beta (3Y Monthly)2.12
PE Ratio (TTM)32.55
EPS (TTM)0.22
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE19 minutes ago

    Cannabis Cultivation Growing- How You Can Profit

    Clean Spark, Inc. (CLSK) has the best in class microgrid solution for the cannabis industry. Today we are highlighting: CleanSpark, Inc. (CLSK), Aurora Cannabis, Inc. (ACB), Tilray, Inc. (NASDAQ: TLRY), Charlotte's Web Holdings, Inc. (CWBHF), and KushCo Holdings, Inc. (KSHB).

  • ACCESSWIRE3 hours ago

    This Undiscovered Brain Stock Could Generate 2,3 or Even 4x Returns

    The marijuana tailwind has been great for the entire sector, but the most well-known companies got there for a reason. It hasn't received the same level of attention, but the neurology sector is seeing a similar tailwind. This is an immense $6 billion market opportunity in the coming years, and these companies are commanding big market valuations as a result.

  • MarketWatch16 hours ago

    Aurora to raise $250 million in convertible debt, stock falls in late trading

    Aurora Cannabis Inc. said late Wednesday that it planned to raise $250 million via convertible debt. Aurora stock fell more than 6% in after-hours trading. The company said it plans to use the cash for Canadian and international expansion, as well as for acquisitions and "working capital requirements" as the businesses grows. Aurora said it will give whoever buys the debt the chance to buy an additional $37.5 million of convertible debt. The notes will be due in 2024. Aurora stock closed up 4.7% to $7.33 during the regular session as the ETFMG Alternative Harvest ETF fell 1.9%.

  • CNW Group18 hours ago

    Aurora Cannabis Announces Private Offering of US $250 Million Of Convertible Senior Notes Due 2024

    Aurora also intends to grant to the initial purchasers of the notes an option to purchase up to an additional US$37.5 million aggregate principal amount of notes. Aurora expects to use the net proceeds from the offering of the notes to support its Canadian and international expansion initiatives, for future acquisitions and for general corporate purposes, including working capital requirements to continue the Company's accelerated growth. The final terms of the notes will be determined by Aurora and the initial purchasers.

  • OTC Markets Group Announces Quarterly Index Performance and Rebalancing
    PR Newswire18 hours ago

    OTC Markets Group Announces Quarterly Index Performance and Rebalancing

    NEW YORK , Jan. 16, 2018 /PRNewswire/ --   OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the fourth quarter 2018 performance ...

  • ACCESSWIRE20 hours ago

    4 Marijuana Stocks Soaring High in January

    As we continue into the new year and watch for the possibilities it may hold, CLS Holdings USA Inc (OTC:CLSH), Aurora Cannabis Inc (TSX: ACB, NYSE: ACB), Charlotte's Web Holdings Inc (CWBHF), and CannTrust Holdings Inc (OTC PINK: CNTTF) represent 4 companies invested in the future of the cannabis industry. CLS Holdings USA Inc (OTC:CLSH) is a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries.

  • A Week of Cannabis Investing Deals & Earnings Reports from GS, BAC, UAL
    Zacks21 hours ago

    A Week of Cannabis Investing Deals & Earnings Reports from GS, BAC, UAL

    Ryan McQueeney covers the latest Brexit news and Snap's executive exodus. He also recaps earnings results from Goldman Sachs, Bank of America, and United Air Lines. Later, he discusses a busy week for deals in the cannabis industry.

  • ACCESSWIREyesterday

    Investors are Cashing in on These Bargains

    HENDERSON, NV / ACCESSWIRE / January 16, 2019 / There are several companies we've found starting 2019 off on a good foot. The market rally has helped investor confidence, which has led to oversold companies ...

  • TheStreet.com2 days ago

    Pot Stocks Are Mixed as Gov. Cuomo Readies Plan for Legalization in New York

    New York state's path to adult-use cannabis legalization will get clearer Tuesday when Gov. Andrew Cuomo lays out his plan to legalize the recreational use and sale of the drug at his State of the State address at 2 p.m. ET. Cuomo, who previously opposed legalization efforts, said in a radio interview that legalized marijuana could raise about $300 million in annual revenue for the state through taxes. Cuomo cited legalization in Massachusetts and pending legalization in New Jersey when questioned about whether the state should legalize.

  • ACCESSWIRE2 days ago

    Best Cannabis Plays on the Market

    HENDERSON, NV / ACCESSWIRE / January 15, 2019 / Below are some of the better opportunities on the cannabis market for investors. One we like a lot isn't even technically a cannabis company at all. Clean ...

  • Market Exclusive2 days ago

    Market Morning: China Buys Oil, Aurora Buys Whistler, Shutdown Hurts Airlines, Brexit Disaster Unfolding

    Stocks Mixed As Everyone Confused About China With nothing compellingly good or bad out about China today, US stock market indexes are mixed. The Dow is down after being up earlier, the S&P is flat, and the Nasdaq is slightly higher as of the early morning. China is reportedly cutting taxes and increasing spending, which […] The post Market Morning: China Buys Oil, Aurora Buys Whistler, Shutdown Hurts Airlines, Brexit Disaster Unfolding appeared first on Market Exclusive.

  • ACCESSWIRE2 days ago

    Stocks Screaming Off Their Lows

    HENDERSON, NV / ACCESSWIRE / January 15, 2019 / The market's performance last year has created some amazing buying opportunities. We've found a few low priced companies with upside potential that are coming ...

  • InvestorPlace2 days ago

    Why Canopy Growth’s Arrival in the U.S. Will Be Huge for CGC Stock

    After a late 2018 plunge, cannabis stocks have been on a tear to start 2019 due to a confluence of tailwinds, as I predicted in December. You've had analysts initiate coverage on the industry with a bullish skew. You've had early stage investors talk up the long-term potential of these companies. M&A chatter has picked up and legislation has moved in the right direction. All together, the big four pot stocks -- Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY), Cronos (NASDAQ:CRON) and Aurora (NYSE:ACB) -- are all up more than 30% in 2019 already, and it's not even halfway through January. This trend will persist because 2019 will mark the year that cannabis stocks enter into the U.S. market. The 2018 Farm Bill legalized hemp across America. But, Canadian cannabis companies have had a tough time entering the U.S. market due to cross-border restrictions. Canopy has worked around the restrictions, and was recently awarded a license to process and produce hemp in the state of New York. CGC stock rose 10% in response to the news. InvestorPlace - Stock Market News, Stock Advice & Trading Tips This is more than just a one-off catalyst. The New York State hemp license is the beginning a multi-quarter and multi-year excursion for Canopy into the multi-billion dollar U.S. CBD market. As the company embarks on this excursion, its leadership position will grow, its moat will grow, revenues will grow, profits will grow, visibility will grow and CGC stock will rise. As such, now isn't the time to sell CGC stock. Instead, it's the time to double-down on the long-term bull thesis of Canopy turning into a $100 billion company one day thanks to the global proliferation of legal CBD products, and Canopy's ability to stay at the top of this burgeoning market. ### CGC: Buy the Rumor & Buy the News For contextual purposes, let's provide a timeline of what has transpired over the past few weeks and why CGC stock is up 60% since Dec. 20. First, on Dec. 20, U.S. President Donald Trump signed into law the 2018 Farm Bill, which nationally legalized hemp. In response, Canopy Growth issued a press release commending the U.S. on passing this bill, and saying that Canopy is ready for a U.S. market launch. Roughly two weeks later, Canopy talked about its hemp production potential in Canada, and its desire and capacity to replicate that production in the now legal U.S. market. A few days after that press release, Canopy announced it had received a groundbreaking New York State license to do just that. In other words, the writing has been on the wall since the Farm Bill passed that Canopy was going to enter the U.S. market. Investors sniffed out that a potential licensing deal was in the works, and bid up CGC stock 60% in anticipation of that deal. Yet, even though this was a massive "buy the rumor" rally, you didn't get a typical "sell the news" response. Instead, you got "buy the rumor, buy the news", as CGC stock rose 10% in response to the New York State license news. * 10 Companies That Could Post Decelerating Profits Why? Because the implications of this license are huge, and indeed big enough to keep bulls in control and bears on their heels. ### The U.S. CBD Push Has Begun Canopy isn't just going to produce industrial hemp in New York, and stop there. Instead, this is just the first step of what will turn a multi-year expansion into the multi-billion dollar U.S. hemp market. Thanks to the passing of the Farm Bill, some industry insiders peg this market as measuring in at $22 billion in revenues within the next several years. Canopy's market cap is just $13 billion. Thus, this company is in the very early stages of entering a market that is twice the size of the company. This opportunity comes on top of early stage growth in a Canadian cannabis market that projects to also be a $10 billion market one day. All together, the U.S CBD push from Canopy has begun. It won't stop anytime soon. That means big growth is in store for the company over the next several quarters. Such big growth will keep bulls in control, bears on their heels and the stock on a winning trajectory. As such, the outlook for CGC stock to keep rallying in the near to medium term is quite favorable. ### Canopy Growth Is a $100 Billion Company In The Making The big picture behind CGC stock is that this is a company that is second-to-none in terms of size, innovation, leadership, resources, production capacity and expansion in a rapidly growing global CBD market that projects to be huge one day. There's plenty of reason to believe, given CBD's medicinal and recreational applications and widespread use among younger demographics, that the global CBD market will be as big as the global alcohol and tobacco markets one day. Both of those markets are in the $700 billion to $1 trillion-plus range. Conservatively, let's say the cannabis market maxes out around $500 billion in a decade. Let's also say that Canopy only controls about 5% of the global market, and runs at an alcoholic beverage market average of 30% operating margins. * 7 Video Game Stocks on Steep Discount Back of the envelope calculations produce $25 billion revenue potential and $7.5 billion operating profit potential for CGC within a decade. Taking out 20% for taxes and throwing a market-average 16x multiple on the net profits, one can easily see how CGC stock could be worth nearly $100 billion in a decade. That potential valuation is 10 years away. CGC stock has a market cap of just over $10 billion today. Thus, this is a potential ten-bagger over the next decade. Granted, ten years is a long time, and a lot could happen between now and then. But, a New York State hemp license is a big step in the right direction toward CGC stock realizing its $100 billion potential. ### Bottom Line on CGC Stock A New York State hemp license is big news, and a huge step toward this company maintaining its leadership position in the rapidly growing global CBD market. So long as this company keeps taking steps to defend market share, CGC stock has the potential to turn into a $100 billion company one day. As of this writing, Luke Lango was long CGC and CRON. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Key Emerging-Market Stocks to Buy for Contrarian Investors * 7 Stocks at Risk of the Global Smartphone Slowdown * 7 Pharmaceutical Stocks That Just Raised Prices This Year Compare Brokers The post Why Canopy Growth's Arrival in the U.S. Will Be Huge for CGC Stock appeared first on InvestorPlace.

  • ACCESSWIRE2 days ago

    Today's Research Reports on Trending Tickers: Aurora Cannabis and Canopy Growth

    NEW YORK, NY / ACCESSWIRE / January 15, 2019 / Wall Street extended losses on Monday as concerns of a global economic slowdown were reignited on weaker-than-expected economic data from China. In December, ...

  • Aurora Cannabis makes a ‘blessed’ buy of organic marijuana producer
    MarketWatch2 days ago

    Aurora Cannabis makes a ‘blessed’ buy of organic marijuana producer

    Aurora Cannabis Inc. said Monday it intends to acquire the one of the last independent members of the so-called “blessed eight,” a group of marijuana companies given the first approval to move cannabis genetics from the black market into the legal regime.

  • Cannabis Investing News: Why CHC & ACB Stock Climbed Today
    Zacks3 days ago

    Cannabis Investing News: Why CHC & ACB Stock Climbed Today

    Cannabis investors saw a pair of notable moves in popular stocks on Monday, with Canopy Growth (CGC) moving 11% and Aurora Cannabis (ACB) adding nearly 7% on the back of exciting deals for both companies.

  • Big Banks Kick Off Earnings Season & Today's Trending Stocks: LULU, ACB
    Zacks3 days ago

    Big Banks Kick Off Earnings Season & Today's Trending Stocks: LULU, ACB

    Ryan McQueeney discusses weak economic data from China as well as news involving Lululemon and Aurora Cannabis. He also recaps Citigroup's earnings results and previews the upcoming reports of JPMorgan and Wells Fargo.

  • TheStreet.com3 days ago

    Aurora Cannabis Acquires Canadian Medical Marijuana Brand Whistler

    announced Monday that it was bolstering its presence in the western part of the country through the purchase of privately held British Columbia-based Whistler Medical Marijuana. The companies have entered into a letter of intent that will see Aurora acquire all issued and outstanding shares of Whistler for about $175 million. Whistler is one of Canada's most recognized brands and is one of the country's original 10 licensed cannabis producers as well as the first licensed producer to obtain organic certification.

  • Benzinga3 days ago

    Aurora To Acquire Organic Cannabis Producer Whistler For $175M

    Canada-based Aurora Cannabis Inc. (NYSE: ACB) announced Monday it's entering into a letter of intent to acquire privately-held Whistler Medical Marijuana Corporation. The all-stock deal is valued at up to $175 million, which also includes future milestone payments related to Whistler reaching certain operational goals. Whistler Medical Marijuana Corporation is a Canadian certified organic cannabis producer that operates in both medical and adult-use markets.

  • ACCESSWIRE3 days ago

    The Biggest Medicinal Cannabis Developments of 2019

    Canada became the first country in the industrialized world to legalize recreational marijuana. In fact, Cowen, U.S. cannabis sales alone could reach $80 billion by 2030- an increase of $5 billion from earlier estimates, and a 4% compound annual growth rate. Piper Jaffray believes the market for legal cannabis could be worth $15 billion to $50 billion a year, with global sales growing to $250 billion to $500 billion.

  • ACCESSWIRE3 days ago

    Today's Research Reports on Trending Tickers: Aurora Cannabis and Tilray

    NEW YORK, NY / ACCESSWIRE / January 14, 2019 / U.S. equities posted strong weekly gains, however, stock closed lower for the day on Friday on concerns over an ongoing U.S. government shutdown and worries ...

  • ACCESSWIRE3 days ago

    Best Bounces to Play the Rally

    HENDERSON, NV / ACCESSWIRE / January 14, 2019 / With the market rallying this week, several oversold stocks are starting to make solid gains. We've found a few stocks that look set up to continue this ...

  • MarketWatch3 days ago

    Aurora Cannabis to buy Whistler Medical Marijuana in a $132 million stock deal

    Shares of Aurora Cannabis Inc. gained 0.8% in premarket trade Monday, after the Canada-based company announced a deal to buy Whistler Medical Marijuana Corp. in a stock deal valued at up to C$175 million ($131.8 million). Whistler, which sells medical cannabis derivatives internationally to Australia and the Cayman Islands, and plans to pursue additional international opportunities, is one of Canada's original 10 licensed producers, and was the first producer to obtain organic certification, Aurora said. Once Whister's second facility is fully operational, expected in Summer 2019, it will have production capacity of over 5,000 kilograms a year. "This transaction adds an iconic, organic certified BC-based brand with exceptional traction and a significant price premium in both the medical and retail markets," said Aurora Chief Executive Terry Booth. Aurora's stock has tumbled 39.4% over the past three months through Friday, while the ETFMG Alternative Harvest ETF has dropped 21.5% and the S&P 500 has lost 6.2%.

  • CNW Group3 days ago

    Aurora to Acquire Whistler

    Aurora to Acquire Whistler

  • PR Newswire3 days ago

    Aurora to Acquire Whistler

    WKN: A1C4WM) announced today that the Company has entered into a letter of intent ("LOI") to acquire all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation ("Whistler"), in an all-share transaction valued at up to approximately $175 million, including certain milestone payments (the "Transaction").